$100.00
IGF-1 LR3 (Long R3 Insulin-Like Growth Factor-1) is a synthetic, long-acting analog of IGF-1. It is designed to have a much longer half-life than natural IGF-1 and stronger activity at IGF receptors.
Availability: In Stock
IGF-1 LR3 (Long R3 Insulin-Like Growth Factor-1) is a synthetic, long-acting analog of IGF-1. It is designed to have a much longer half-life than natural IGF-1 and stronger activity at IGF receptors.
It is not FDA-approved for general use and is typically sold as a research compound.
IGF-1 LR3:
Mimics insulin-like growth factor-1
Binds to IGF-1 receptors in muscle and other tissues
Stimulates cell growth and proliferation
Increases nutrient uptake into muscle cells
Has reduced binding to IGF binding proteins (which extends activity)
Unlike growth hormone (GH), which stimulates your body to produce IGF-1, IGF-1 LR3 acts directly at the receptor level.
A 1 mg vial refers to the total peptide amount in the vial.
Because IGF-1 LR3 is extremely potent, dosing is typically measured in micrograms (mcg), not milligrams. Even small dosing differences can significantly affect blood glucose and tissue response.
Commonly talked about for:
Muscle hypertrophy
Increased nutrient partitioning
Fat loss support
Local muscle growth (when injected intramuscularly)
However, outcomes vary significantly and carry meaningful risks.
IGF-1 LR3 is much more aggressive than GH secretagogues like:
Ipamorelin
Key risks include:
Hypoglycemia (low blood sugar)
Organ enlargement with long-term use
Potential tumor growth acceleration (IGF pathway strongly influences cell proliferation)
Insulin resistance
Edema / water retention
Because it directly stimulates growth pathways, it carries more systemic risk than milder peptides.
Reviews
There are no reviews yet.